Insider · CIK 0001737428

Patel Chintu

Reports to the SEC for 1 company · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001737428

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	AMRXAmneal Pharmaceuticals, Inc.A Award	Director, Co-CEO	AAward	+6.38M sh	—	—	6,381,734
2026-03-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+92.6K sh	—	—	1,417,504
2026-03-04	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Director, Co-CEO	FTax Payment	−29K sh	$13.30	−$385K	1,388,521
2026-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−92.6K sh	—	—	185,185
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+59.9K sh	—	—	923,964
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Director, Co-CEO	FTax Payment	−17.1K sh	$13.31	−$228K	906,852
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+734K sh	—	—	1,640,796
2026-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Director, Co-CEO	FTax Payment	−316K sh	$13.31	−$4.2M	1,324,911
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−59.9K sh	—	—	179,795
2026-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−734K sh	—	—	0
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+545K sh	—	—	544,663
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+191K sh	—	—	190,632
2026-03-02	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+354K sh	—	—	354,031
2025-03-04	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+92.6K sh	—	—	910,561
2025-03-04	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Director, Co-CEO	FTax Payment	−46.5K sh	$8.84	−$411K	864,033
2025-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−92.6K sh	—	—	277,778
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+580K sh	—	—	1,092,276
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Director, Co-CEO	FTax Payment	−274K sh	$8.76	−$2.4M	817,969
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−580K sh	—	—	0
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+890K sh	—	—	890,410
2025-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+240K sh	—	—	239,726
2024-03-04	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+370K sh	—	—	370,370
2024-03-04	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+1.33M sh	—	—	1,333,334
2023-11-07	AMRXAmneal Pharmaceuticals, Inc.J Other	Director, Co-CEO	JOther	+24.8M sh	—	—	24,753,252
2023-11-07	AMRXAmneal Pharmaceuticals, Inc. · Class B Common Stock and Common UnitsJ Other	Director, Co-CEO	JOther	−24.8M sh	—	—	0
2023-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+734K sh	—	—	733,944
2022-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+1.16M sh	—	—	1,159,420
2021-12-16	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director, Co-CEO	PPurchase	+50K sh	$4.25	+$213K	512,566
2021-12-15	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director, Co-CEO	PPurchase	+100K sh	$4.13	+$413K	462,566
2021-03-01	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+927K sh	—	—	926,640
2020-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+6,459 sh	—	—	362,566
2020-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−6,459 sh	—	—	0
2020-03-10	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director, Co-CEO	PPurchase	+100K sh	$3.09	+$309K	356,107
2020-03-04	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director, Co-CEO	PPurchase	+58.8K sh	$3.97	+$233K	256,107
2020-03-03	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director, Co-CEO	PPurchase	+157K sh	$3.88	+$607K	197,342
2020-03-02	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director, Co-CEO	PPurchase	+34.7K sh	$3.87	+$134K	40,803
2020-02-27	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+1.27M sh	—	—	1,266,490
2019-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	+6,107 sh	—	—	6,107
2019-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Co-CEO	MExercise/Conversion	−6,107 sh	—	—	0
2019-05-06	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director, Co-CEO	AAward	+28K sh	—	—	28,044
2019-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+6,459 sh	—	—	6,459
2018-07-05	AMRXAmneal Pharmaceuticals, Inc.J Other	Director, Co-CEO	JOther	+24.8M sh	—	—	24,753,252
2018-07-05	AMRXAmneal Pharmaceuticals, Inc. · Common UnitsJ Other	Director, Co-CEO	JOther	+24.8M sh	—	—	24,753,252
2018-05-07	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director, Co-CEO	AAward	+25K sh	—	—	24,977
2018-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Co-CEO	AAward	+6,107 sh	—	—	6,107

Recent filings

Accepted (ET)
Aug 124
Patel Chintu0001628280-26-056297
SEC(opens sec.gov)
Mar 274/A
Patel Chintu0001628280-26-021746
SEC(opens sec.gov)
Mar 54
Patel Chintu0001628280-26-015285
SEC(opens sec.gov)
Mar 34
Patel Chintu0001628280-26-013900
SEC(opens sec.gov)
Mar 54
Patel Chintu0001628280-25-010688
SEC(opens sec.gov)

Companies

Amneal Pharmaceuticals, Inc.Director, Co-CEOAMRX

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807